IMCR Stock Risk & Deep Value Analysis

Immunocore Holdings plc

Healthcare • Biotechnology

DVR Score

7.8

out of 10

Solid Pick

The Bottom Line on IMCR

We analyzed Immunocore Holdings plc using our deep value framework. Sign in to see our full verdict and DVR Score.

We ran IMCR through our deep value framework — analyzing financial health, distress signals, competitive moat, and risk factors. Here's what we found.

Updated Oct 5, 2025•Run Fresh Analysis →

About Immunocore Holdings plc (IMCR)

Sector

Healthcare

Industry

Biotechnology

Market Cap Category

small

Market Cap

$1.72B

IMCR Deep Value Analysis

Immunocore boasts a validated ImmTAX platform, proven by KIMMTRAK's approval, targeting historically undruggable intracellular antigens. This unique technology, coupled with a diverse pipeline for vast oncology and infectious disease markets (e.g., PRAME), presents significant 10x potential. Strong cash runway and experienced leadership further support its vision. However, success hinges critically on high-risk clinical trial outcomes for pipeline assets and navigating fierce competition in larger indications, representing the primary hurdle for multi-bagger returns.

IMCR Financial Health Metrics

Market Cap

$1.72B

📊 Explore More Stock Analysis

Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential.

Analyze Any Stock →View Top 100 Deep Value Stocks →

Important Disclaimer – Not Financial Advice

Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.

All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research and consult with a qualified financial advisor.

More Resources to Boost Your Portfolio

Explore our other guides and tools to maximize your investment returns